44 results on '"Xiang, Nijuan"'
Search Results
2. Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015
3. Assessing Change in Avian Influenza A(H7N9) Virus Infections During the Fourth Epidemic — China, September 2015–August 2016
4. Clusters of Human Infection and Human-to-Human Transmission of Avian Influenza A(H7N9) Virus, 2013-2017
5. Lessons from an active surveillance pilot to assess the pneumonia of unknown etiology surveillance system in China, 2016: the need to increase clinician participation in the detection and reporting of emerging respiratory infectious diseases
6. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019
7. Risk Factors for Influenza A(H7N9) Disease— China, 2013
8. Risk Factors for Severe Illness with 2009 Pandemic Influenza A (H1N1) Virus Infection in China
9. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China
10. Risk Factors for Human Illness with Avian Influenza A (H5N1) Virus Infection in China
11. Comparison of Epidemiological Characteristics and Transmissibility of Different Strains of COVID-19 Based on the Incidence Data of All Local Outbreaks in China as of March 1, 2022
12. Human influenza A(H7n9) virus infection associated with poultry farm, Northeastern China
13. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
14. Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013
15. Transmission dynamics, border entry screening, and school holidays during the 2009 influenza A (H1N1) pandemic, China
16. Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
17. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010–2012
18. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China
19. Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006
20. Human Streptococcus suis outbreak, Sichuan, China
21. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
22. Evaluating the importation of yellow fever cases into China in 2016 and strategies used to prevent and control the spread of the disease
23. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
24. Incubation period for human cases of avian influenza a (H5N1) infection, China
25. Knowledge, attitudes and practices (KAP) relating to avian influenza in urban and rural areas of China
26. Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012
27. Sero-epidemiologic study of influenza A(H7N9) infection among exposed populations, China 2013-2014
28. Comparison of the first three waves of avian influenza A(H7N9) virus circulation in the mainland of the People’s Republic of China
29. Risk Factors for Influenza A(H7N9) Disease in China, a Matched Case Control Study, October 2014 to April 2015
30. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012
31. Virological and serological study of human infection with swine influenza A H1N1 virus in China
32. Seroprevalence of Antibodies to Highly Pathogenic Avian Influenza A (H5N1) Virus among Close Contacts Exposed to H5N1 Cases, China, 2005–2008
33. Knowledge, attitudes and practices (KAP) relating to avian influenza in urban and rural areas of China
34. Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China
35. The first confirmed human case of avian influenza A (H5N1) in Mainland China
36. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China
37. The Epidemiological Characteristics of Mpox Cases - China, 2023.
38. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China.
39. Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016.
40. Assessing Change in Avian Influenza A(H7N9) Virus Infections During the Fourth Epidemic - China, September 2015-August 2016.
41. [Epidemiological characteristics of Middle East Respiratory Syndrome outbreak in the Republic of Korea, 2015].
42. [Estimation of hospitalization rate of laboratory confirmed influenza cases in Jingzhou city, Hubei province, 2010-2012].
43. [Epidemiological characteristics of human avian influenza A (H7N9) virus infection in China].
44. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.